These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21972727)

  • 41. Regular tart cherry intake alters abdominal adiposity, adipose gene transcription, and inflammation in obesity-prone rats fed a high fat diet.
    Seymour EM; Lewis SK; Urcuyo-Llanes DE; Tanone II; Kirakosyan A; Kaufman PB; Bolling SF
    J Med Food; 2009 Oct; 12(5):935-42. PubMed ID: 19857054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Metabolic syndrome: "common soil" for diabetes and atherosclerosis. Novel approaches to an integrated therapy].
    Hanefeld M; Metzler W; Köhler C; Schaper F
    Herz; 2006 May; 31(3):246-54; quiz 255. PubMed ID: 16770562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.
    Xie Z; Hao H; Tong C; Cheng Y; Liu J; Pang Y; Si Y; Guo Y; Zang L; Mu Y; Han W
    Stem Cells; 2016 Mar; 34(3):627-39. PubMed ID: 26523620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects.
    Chu JW; Abbasi F; Lamendola C; McLaughlin T; Reaven GM; Tsao PS
    Diab Vasc Dis Res; 2005 Feb; 2(1):37-41. PubMed ID: 16305071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
    Martínez-Clemente M; Clària J; Titos E
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infliximab and insulin resistance.
    Ursini F; Naty S; Grembiale RD
    Autoimmun Rev; 2010 Jun; 9(8):536-9. PubMed ID: 20060507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential application of non-flavonoid phenolics in diabetes: antiinflammatory effects.
    Miranda J; Lasa A; Aguirre L; Fernandez-Quintela A; Milton I; Portillo MP
    Curr Med Chem; 2015; 22(1):112-31. PubMed ID: 25139172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting Inflammation in the Prevention and Treatment of Type 2 Diabetes: Insights From CANTOS.
    Verma S; Mathew V; Farkouh ME
    J Am Coll Cardiol; 2018 May; 71(21):2402-2404. PubMed ID: 29793628
    [No Abstract]   [Full Text] [Related]  

  • 49. Large language models for diabetes care: Potentials and prospects.
    Sheng B; Guan Z; Lim LL; Jiang Z; Mathioudakis N; Li J; Liu R; Bao Y; Bee YM; Wang YX; Zheng Y; Tan GSW; Ji H; Car J; Wang H; Klonoff DC; Li H; Tham YC; Wong TY; Jia W
    Sci Bull (Beijing); 2024 Mar; 69(5):583-588. PubMed ID: 38220476
    [No Abstract]   [Full Text] [Related]  

  • 50. [Standardisation of Perioperative Antiinflammatory Therapy].
    Cursiefen C; Heiligenhaus A
    Klin Monbl Augenheilkd; 2019 May; 236(5):634-635. PubMed ID: 31096281
    [No Abstract]   [Full Text] [Related]  

  • 51. CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review.
    Breyton AE; Lambert-Porcheron S; Laville M; Vinoy S; Nazare JA
    Front Endocrinol (Lausanne); 2021; 12():666008. PubMed ID: 34566883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoglycemic Effect of Laminaria japonica Polysaccharide in a Type 2 Diabetes Mellitus Mouse Model.
    Li X; Yu Z; Long S; Guo Y; Duan D
    ISRN Endocrinol; 2012; 2012():507462. PubMed ID: 23209930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
    Esser N; Legrand-Poels S; Piette J; Scheen AJ; Paquot N
    Diabetes Res Clin Pract; 2014 Aug; 105(2):141-50. PubMed ID: 24798950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammation and insulin resistance.
    Shoelson SE; Lee J; Goldfine AB
    J Clin Invest; 2006 Jul; 116(7):1793-801. PubMed ID: 16823477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin resistance and chronic cardiovascular inflammatory syndrome.
    Fernández-Real JM; Ricart W
    Endocr Rev; 2003 Jun; 24(3):278-301. PubMed ID: 12788800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Chronic mild inflammation links obesity, metabolic syndrome, atherosclerosis and diabetes].
    Andel M; Polák J; Kraml P; Dlouhý P; Stich V
    Vnitr Lek; 2009; 55(7-8):659-65. PubMed ID: 19731872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Type 2 diabetes and anti-inflammatory agents: new therapeutic prospects?].
    Esser N; Paquot N; Scheen AJ
    Rev Med Suisse; 2011 Aug; 7(306):1614-8, 1620. PubMed ID: 21972727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
    Esser N; Paquot N; Scheen AJ
    Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.